[Federal Register Volume 88, Number 21 (Wednesday, February 1, 2023)]
[Notices]
[Pages 6765-6766]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-02062]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Maximizing Investigators' Research Award A Study
Section.
Date: February 27-28, 2023.
Time: 8:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesdan Hotel, Tapestry Collection by Hilton, 8120
Wisconsin Ave, Bethesda, MD 20814.
Contact Person: Mollie Kim Manier, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-0510,
[email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Neurological, Mental and Behavioral Health
Study Section.
Date: February 27-28, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Melrose Hotel, 2430 Pennsylvania Ave. NW, Washington, DC
20037.
Contact Person: Allison Kurti, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 1007J, Bethesda, MD 20892, (301) 594-1814,
[email protected].
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group; Imaging Technology
Development Study Section.
Date: February 27-28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Guo Feng Xu, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5122, MSC 7854, Bethesda, MD 20892, (301) 237-
9870, [email protected].
Name of Committee: Healthcare Delivery and Methodologies
Integrated Review Group; Health Promotion in Communities Study
Section.
Date: February 27-28, 2023.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aubrey Spriggs Madkour, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1000C, Bethesda, MD 20892, (301)
594-6891, [email protected].
[[Page 6766]]
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Clinical Oncology Study Section.
Date: February 27-28, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laura Asnaghi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institute of Health, 6701
Rockville Drive, Room 6200, MSC 7804, Bethesda, MD 20892, (301) 443-
1196, [email protected].
Name of Committee: Oncology 2--Translational Clinical Integrated
Review Group; Molecular Cancer Diagnosis and Classification Study
Section.
Date: February 27-28, 2023.
Time: 9:15 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lawrence Ka-Yun Ng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6152, MSC 7804, Bethesda, MD
20892, 301-435-1719, [email protected].
Name of Committee: Genes, Genomes, and Genetics Integrated
Review Group; Genetics of Health and Disease Study Section.
Date: February 27-28, 2023.
Time: 9:30 a.m. to 8:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Christopher Payne, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Rm. 2208, Bethesda, MD 20892, 301-402-
3702, [email protected].
Name of Committee: Oncology 1--Basic Translational Integrated
Review Group; Biochemical and Cellular Oncogenesis Study Section.
Date: February 27-28, 2023.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Jian Cao, MD, Scientific Review Officer, Center
for Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Bethesda, MD 20892 (301) 827-5902, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-22-056: Research Resource for Human Organs and Tissues.
Date: February 27, 2023.
Time: 2:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David Balasundaram, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD
20892, 301-435-1022, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: January 26, 2023.
David W Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-02062 Filed 1-31-23; 8:45 am]
BILLING CODE 4140-01-P